tiprankstipranks
Eupraxia Pharmaceuticals, Inc. (TSE:EPRX)
TSX:EPRX
Canadian Market
EPRX
Eupraxia Pharmaceuticals
RESEARCH TOOLSreports
Want to see TSE:EPRX full AI Analyst Report?

Eupraxia Pharmaceuticals (EPRX) Financial Statements

71 Followers

Eupraxia Pharmaceuticals Financial Overview

Eupraxia Pharmaceuticals's market cap is currently C$610.80M. The company's EPS TTM is C$-1.05; its P/E ratio is -6.30; Eupraxia Pharmaceuticals is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is C$-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00C$ 0.00C$ 0.00
Gross Profit$ -241.88K$ -163.47K$ -158.05KC$ -193.27KC$ -111.53K
Operating Income$ -39.11M$ -25.71M$ -28.53MC$ -23.58MC$ -18.47M
EBITDA$ -38.86M$ -23.43M$ -28.16MC$ -22.14MC$ -21.96M
Net Income$ -39.25M$ -24.28M$ -28.15MC$ -23.26MC$ -22.99M
Balance Sheet
Cash & Short-Term Investments$ 80.42M$ 33.10M$ 19.34MC$ 24.74MC$ 29.90M
Total Assets$ 85.99M$ 34.94M$ 20.12MC$ 25.88MC$ 31.22M
Total Debt$ 154.08K$ 71.86K$ 10.45MC$ 10.55MC$ 9.49M
Net Debt$ -80.26M$ -33.03M$ -8.83MC$ -14.19MC$ -11.40M
Total Liabilities$ 5.69M$ 3.10M$ 19.23MC$ 14.51MC$ 11.67M
Stockholders' Equity$ 81.89M$ 33.40M$ 2.21MC$ 12.86MC$ 20.39M
Cash Flow
Free Cash Flow$ -29.65M$ -30.10M$ -21.09MC$ -19.08MC$ -15.07M
Operating Cash Flow$ -29.05M$ -29.99M$ -21.02MC$ -18.78MC$ -14.64M
Investing Cash Flow$ -599.26K$ -75.16K$ -73.20KC$ 8.70MC$ -14.45M
Financing Cash Flow$ 77.39M$ 45.78M$ 21.35MC$ 13.52MC$ 49.92M

Eupraxia Pharmaceuticals Earnings and Revenue History

Income Statement >

Eupraxia Pharmaceuticals Debt to Assets

Balance Sheet >

Eupraxia Pharmaceuticals Cash Flow

Cash Flow >

Eupraxia Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >